HNB
BMY.RT

Huntington National Bank’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Huntington National Bank’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,980
Closed -$2K – 1947
2020
Q4 		$2K Sell
3,980
-406
-9% -$865 ﹤0.01% 1524
2020
Q3 		$10K Sell
4,386
-779
-15% -$2.23K ﹤0.01% 1234
2020
Q2 		$19K Sell
5,165
-714
-12% -$2.58K ﹤0.01% 1059
2020
Q1 		$22K Buy
+5,879
New +$19.4K ﹤0.01% 1010

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Huntington National Bank's BMY.RT Position: Q1 2021 in Review

Huntington National Bank sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 3,980 shares — an estimated $2K sold.

Huntington National Bank first reported a position in BMY.RT in Q1 2020 and held it in 4 quarters. The position peaked at $22K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Huntington National Bank reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Huntington National Bank sold 3,980 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $2K.
  • Huntington National Bank first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2020 and held it in 4 quarters.
  • Huntington National Bank's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $22K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Huntington National Bank's 13F filing for Q1 2021, filed 12 Apr 2021.